Group One Trading
ATRS

Group One Trading’s Antares Pharma, Inc. ATRS Stock Holding History

Group One Trading’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-300
Closed -$1K – 8909
2022
Q1 		$1K Sell
300
-1,100
-79% -$3.99K ﹤0.01% 7930
2021
Q4 		$5K Sell
1,400
-2,200
-61% -$7.69K ﹤0.01% 7678
2021
Q3 		$13K Sell
3,600
-55,800
-94% -$226K ﹤0.01% 7407
2021
Q2 		$259K Sell
59,400
-5,700
-9% -$23.2K ﹤0.01% 4948
2021
Q1 		$268K Buy
65,100
+23,800
+58% +$103K ﹤0.01% 4710
2020
Q4 		$165K Buy
41,300
+14,400
+54% +$46.6K ﹤0.01% 4208
2020
Q3 		$73K Buy
26,900
+10,500
+64% +$29.1K ﹤0.01% 4404
2020
Q2 		$45K Sell
16,400
-46,800
-74% -$131K ﹤0.01% 4436
2020
Q1 		$149K Sell
63,200
-33,700
-35% -$115K ﹤0.01% 2981
2019
Q4 		$455K Sell
96,900
-19,200
-17% -$78.6K ﹤0.01% 2504
2019
Q3 		$388K Buy
116,100
+76,100
+190% +$251K ﹤0.01% 2549
2019
Q2 		$132K Sell
40,000
-69,900
-64% -$202K ﹤0.01% 3142
2019
Q1 		$333K Buy
109,900
+19,600
+22% +$63.5K ﹤0.01% 2279
2018
Q4 		$246K Buy
90,300
+60,500
+203% +$199K ﹤0.01% 2524
2018
Q3 		$100K Buy
29,800
+19,600
+192% +$60.5K ﹤0.01% 3541
2018
Q2 		$26K Sell
10,200
-9,600
-48% -$23.9K ﹤0.01% 4275
2018
Q1 		$44K Buy
19,800
+400
+2% +$900 ﹤0.01% 3730
2017
Q4 		$39K Buy
19,400
+17,700
+1,041% +$38.5K ﹤0.01% 3856
2017
Q3 		$6K Sell
1,700
-800
-32% -$2.47K ﹤0.01% 4447
2017
Q2 		$8K Buy
+2,500
New +$7.09K ﹤0.01% 4302
2013
Q3 		– Sell
-78,100
Closed -$325K – 5717
2013
Q2 		$325K Buy
+78,100
New +$302K 0.01% 1719

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's ATRS Position: Q2 2022 in Review

Group One Trading sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 13,427 shares — an estimated $55K sold.

Group One Trading first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $600K in Q4 2013. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Group One Trading reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 13,427 Antares Pharma, Inc. shares in Q2 2022, an estimated $55K.
  • Group One Trading first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
  • Group One Trading's Antares Pharma, Inc. position peaked at $600K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.